Nicolas Guilbaud

2.3k total citations
69 papers, 2.0k citations indexed

About

Nicolas Guilbaud is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Nicolas Guilbaud has authored 69 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 22 papers in Oncology and 12 papers in Organic Chemistry. Recurrent topics in Nicolas Guilbaud's work include Cancer therapeutics and mechanisms (19 papers), Polyamine Metabolism and Applications (12 papers) and Chemical Synthesis and Analysis (6 papers). Nicolas Guilbaud is often cited by papers focused on Cancer therapeutics and mechanisms (19 papers), Polyamine Metabolism and Applications (12 papers) and Chemical Synthesis and Analysis (6 papers). Nicolas Guilbaud collaborates with scholars based in France, Germany and Japan. Nicolas Guilbaud's co-authors include Ghanem Atassi, Laurence Kraus‐Berthier, Alain St. Pierre, Christian Bailly, Stéphane Léonce, Jean‐Marc Barret, Stéphane Vispé, Anna Kruczynski, Annie Valette and Michel Koch and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Nicolas Guilbaud

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Guilbaud France 26 1.2k 481 473 265 191 69 2.0k
Xiongwen Zhang China 34 2.0k 1.7× 529 1.1× 364 0.8× 385 1.5× 134 0.7× 95 2.9k
Anna Kruczynski France 26 1.3k 1.1× 779 1.6× 313 0.7× 257 1.0× 226 1.2× 71 2.1k
Valentina Zuco Italy 27 1.8k 1.5× 579 1.2× 420 0.9× 401 1.5× 199 1.0× 70 2.4k
Yong‐Su Zhen China 26 1.5k 1.3× 658 1.4× 356 0.8× 255 1.0× 173 0.9× 154 2.3k
Lucı́lia Saraiva Portugal 26 1.2k 1.1× 580 1.2× 390 0.8× 264 1.0× 77 0.4× 109 2.1k
Andrzej Składanowski Poland 27 2.1k 1.8× 1.1k 2.2× 548 1.2× 212 0.8× 136 0.7× 62 2.9k
Michael C. Bibby United Kingdom 20 778 0.7× 389 0.8× 291 0.6× 300 1.1× 108 0.6× 47 1.7k
Francis Darro Belgium 28 1.5k 1.3× 404 0.8× 744 1.6× 232 0.9× 113 0.6× 73 2.7k
Jinlei Bian China 26 1.1k 0.9× 392 0.8× 441 0.9× 249 0.9× 211 1.1× 98 1.9k
Shingo Dan Japan 26 1.4k 1.2× 493 1.0× 278 0.6× 294 1.1× 191 1.0× 95 2.3k

Countries citing papers authored by Nicolas Guilbaud

Since Specialization
Citations

This map shows the geographic impact of Nicolas Guilbaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Guilbaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Guilbaud more than expected).

Fields of papers citing papers by Nicolas Guilbaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Guilbaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Guilbaud. The network helps show where Nicolas Guilbaud may publish in the future.

Co-authorship network of co-authors of Nicolas Guilbaud

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Guilbaud. A scholar is included among the top collaborators of Nicolas Guilbaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Guilbaud. Nicolas Guilbaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muller, David C., Théo Goullet de Rugy, Rémi Samain, et al.. (2019). eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. JCI Insight. 4(21). 25 indexed citations
2.
Larminat, Florence, Dennis Gómez, Philippe Frit, et al.. (2017). The DNA-Binding Polyamine Moiety in the Vectorized DNA Topoisomerase II Inhibitor F14512 Alters Reparability of the Consequent Enzyme-Linked DNA Double-Strand Breaks. Molecular Cancer Therapeutics. 16(10). 2166–2177. 6 indexed citations
3.
Tierny, Dominique, François Serres, Emmanuel Bouchaert, et al.. (2015). Phase I Clinical Pharmacology Study of F14512, a New Polyamine-Vectorized Anticancer Drug, in Naturally Occurring Canine Lymphoma. Clinical Cancer Research. 21(23). 5314–5323. 19 indexed citations
4.
Thibault, Benoît, Emily Clement, Samuel Meignan, et al.. (2015). F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer. Cancer Letters. 370(1). 10–18. 20 indexed citations
5.
Kruczynski, Anna, Arnaud Pillon, Laurent Créancier, et al.. (2013). F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity. Leukemia. 27(11). 2139–2148. 30 indexed citations
6.
Annereau, Jean‐Philippe, Nicolas Guilbaud, I. Garrido, et al.. (2012). CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans. Journal of Dermatological Science. 69(2). 105–113. 17 indexed citations
7.
8.
Pesnel, Sabrina, Arnaud Pillon, Stéphanie Lerondel, et al.. (2011). 99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation. European Journal of Nuclear Medicine and Molecular Imaging. 38(10). 1832–1841. 8 indexed citations
9.
Annereau, Jean‐Philippe, Charles Dumontet, Thierry Imbert, et al.. (2010). A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment. Leukemia Research. 34(10). 1383–1389. 29 indexed citations
10.
Vispé, Stéphane, Laurent Créancier, Jesper Q. Svejstrup, et al.. (2009). Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA. Molecular Cancer Therapeutics. 8(10). 2780–2790. 141 indexed citations
11.
Annereau, Jean‐Philippe, Stéphane Vispé, Nicolas Guilbaud, et al.. (2009). Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system. Bioorganic & Medicinal Chemistry Letters. 19(9). 2474–2477. 39 indexed citations
12.
Kruczynski, Anna, Isabelle Vandenberghe, Arnaud Pillon, et al.. (2009). Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system. Investigational New Drugs. 29(1). 9–21. 50 indexed citations
13.
Barret, Jean‐Marc, Anna Kruczynski, Stéphane Vispé, et al.. (2008). F14512, a Potent Antitumor Agent Targeting Topoisomerase II Vectored into Cancer Cells via the Polyamine Transport System. Cancer Research. 68(23). 9845–9853. 74 indexed citations
14.
Nakamura, Kazuhide, Eri Taguchi, Tsuyoshi Miura, et al.. (2006). KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties. Cancer Research. 66(18). 9134–9142. 164 indexed citations
15.
Guilbaud, Nicolas, Stéphane Léonce, François Tillequin, et al.. (2002). Acronycine derivatives as promising antitumor agents. Anti-Cancer Drugs. 13(5). 445–449. 35 indexed citations
16.
Morris, Angela, Nicolas Guilbaud, Gordon C. Tucker, et al.. (1997). Eriochrome Black T, structurally related to suramin, inhibits angiogenesis and tumor growth in vivo. Anti-Cancer Drugs. 8(8). 746–755. 18 indexed citations
17.
Morgant, G., Β. Viossat, Stéphane Léonce, et al.. (1997). Synthesis and antitumor activity of the metformin platinum (IV) complex. Crystal structure of the tetrachloro(metformin)platinum (IV) dimethylsulfoxide solvate. Journal of Inorganic Biochemistry. 68(1). 53–59. 32 indexed citations
18.
Pierre, Alain St., Stéphane Léonce, Nicolas Guilbaud, et al.. (1996). Synthesis and Biological Evaluation of 6-(9-Hydroxy-5-methyl(and 5,6-Dimethyl)-6H-pyrido(4,3-b)carbazol-1-yl)picolinic Amides as New Olivacine Derivatives.. Chemical and Pharmaceutical Bulletin. 44(11). 2169–2172. 5 indexed citations
19.
Sombié, Pierre Alexandre Eric Djifaby, Ghanem Atassi, Nicolas Guilbaud, et al.. (1994). Synthesis and Evaluation of 9-Hydroxy-5-methyl- (and 5,6-dimethyl)-6H-pyrido[4,3-b]carbazole-1-N-[(dialkylamino)alkyl]carboxamides, a New Promising Series of Antitumor Olivacine Derivatives. Journal of Medicinal Chemistry. 37(15). 2445–2452. 33 indexed citations
20.
Cros, Suzy, et al.. (1992). In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model. Cancer Chemotherapy and Pharmacology. 30(6). 491–494. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiongwen Zhang Breakdown of academic impact, for papers by Anna Kruczynski Breakdown of academic impact, for papers by Valentina Zuco Breakdown of academic impact, for papers by Yong‐Su Zhen Breakdown of academic impact, for papers by Lucı́lia Saraiva Breakdown of academic impact, for papers by Andrzej Składanowski Breakdown of academic impact, for papers by Michael C. Bibby Breakdown of academic impact, for papers by Francis Darro Breakdown of academic impact, for papers by Jinlei Bian Breakdown of academic impact, for papers by Shingo Dan
Rankless by CCL
2026